We provide the resources you need to collect the highest quality data rigorously to end the full circle.
We do it through:
Field data collection (F2F)
Telephone data collection (CATI)
Web-data collection (CAWI)
We have strategic partnerships with hospitals and CROs, enhancing our access to anonymized patient records and medical charts. Data from physicians’ practices are collected, then processed, quality-checked and consolidated.
HDS runs several cohort studies and has strategic partnerships with National and Regional registry centers, which allows us access to anonymized patient-level data.
Claims collected from payers or HCPs. The data is captured from health insurers or health care providers.
Applications of RWE
Real-World Evidence can be used for many different objectives from pre-clinical to commercialization, as depicted below
| Preclinical | Phase I-II | Phase III | Peri-Launch | Phase IV |
|---|---|---|---|---|
| Market Sizing | Market Landscape | Competitor Reconnaissance | Registries | Safety Surveillance |
| Unmet Need | Economic Burden | Patient Burden | Global BOls | Continuous Monitoring |
| Patient Profiling | Disease History | Treatment Patterns | Target Product Profile | Tailored Therapeutics |
| Early Modeling | Endpoint Development | CE/BI Modeling | CEAs & BlAs | Health Technology Assessments |
| Instrument Validation | Endpoint Assessment | Labeled Claims | New Indication | |
| Global Value Dossiers | Comparative Effectiveness | |||
| Pricing & Reimbursement | Risk Sharing Arrangements |
| Preclinical |
|---|
| Market Sizing |
| Unmet Need |
| Patient Profiling |
| Early Modeling |
| Phase I-II |
|---|
| Market Landscape |
| Economic Burden |
| Disease History |
| Endpoint Development |
| Instrument Validation |
| Phase III |
|---|
| Competitor Reconnaissance |
| Patient Burden |
| Treatment Patterns |
| CE/BI Modeling |
| Endpoint Assessment |
| Peri-Launch |
|---|
| Registries |
| Global BOls |
| Target Product Profile |
| CEAs & BlAs |
| Labeled Claims |
| Global Value Dossiers |
| Pricing & Reimbursement |
| Phase IV |
|---|
| Safety Surveillance |
| Continuous Monitoring |
| Tailored Therapeutics |
| Health Technology Assessments |
| New Indication |
| Comparative Effectiveness |
| Risk Sharing Arrangements |
The Engine Behind The Know-how
HDI Group integrates unparalleled data, transformative technology, advanced analytics, and domain expertise and puts it seamlessly within reach.
Multiple data types from the world’s most reliable sources, constantly gathered, updated, and usably integrated.
Domain experts worldwide can support you, from sales analytics and forecasting to competitive intelligence, data cleaning, and coding.
Machine learning that projects future-facing, data-based insights.
To know more about our projects and training Contact Us.